Related references
Note: Only part of the references are listed.Changing Epidemiology of Antimicrobial-Resistant Streptococcus pneumoniae in the United States, 2004-2005
Sandra S. Richter et al.
CLINICAL INFECTIOUS DISEASES (2009)
Changes of serotype and genotype in Streptococcus pneumoniae isolates from a Korean hospital in 2007
Jae-Hoon Song et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Population Snapshot of Streptococcus pneumoniae Serotype 19A Isolates before and after Introduction of Seven-Valent Pneumococcal Vaccination for French Children
Farah Mahjoub-Messai et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Temporal Trends of Invasive Streptococcus pneumoniae Serotypes and Antimicrobial Resistance Patterns in Spain from 1979 to 2007
A. Fenoll et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Introduction and Proliferation of Multidrug-Resistant Streptococcus pneumoniae Serotype 19A Clones That Cause Acute Otitis Media in an Unvaccinated Population
Ron Dagan et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis
Heather E. Hsu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Association of Serotype of Streptococcus pneumoniae With Risk of Severe and Fatal Outcome
Simon Rueckinger et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines
Gail L. Rodgers et al.
VACCINE (2009)
Challenges in the evaluation and licensing of new pneumococcal vaccines, 7-8 July 2008, Ottawa, Canada
I. Feavers et al.
VACCINE (2009)
Prevalence of serotype 19A Streptococcus pneumoniae among isolates from US children in 2005-2006 and activity of faropenem
Ian A. Critchley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Temporal and spatial distribution of clonal complexes of Streptococcus pneumoniae isolates resistant to multiple classes of antibiotics in Belgium, 1997 to 2004
Heather Amrine-Madsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine
Carmen Munoz-Almagro et al.
CLINICAL INFECTIOUS DISEASES (2008)
Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era
S. Nunes et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era
Ener Cagri Dinleyici et al.
EXPERT REVIEW OF VACCINES (2008)
Pneumococcal disease in a paediatric population in a hospital of central Italy: A clinical and microbiological case series from 1992 to 2006
Francesca Montagnani et al.
JOURNAL OF INFECTION (2008)
Age- and Serotype-Specific Pediatric Invasive Pneumococcal Disease: Insights from Systematic Surveillance in Santiago, Chile, 1994-2007
Rosanna Lagos et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Population snapshot of emergent streptococcus pneumoniae serotype 19A in the United States, 2005
Matthew R. Moore et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Impact of conjugate pneumococcal vaccines on antibiotic resistance
Ron Dagan et al.
LANCET INFECTIOUS DISEASES (2008)
Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004
Fangjun Zhou et al.
PEDIATRICS (2008)
Phase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adults
Daniel Scott et al.
PEDIATRICS INTERNATIONAL (2008)
Streptococcus pneumoniae serotype 19A in children, South Korea
Eun Hwa Choi et al.
EMERGING INFECTIOUS DISEASES (2008)
Outbreak of Streptococcus pneumoniae serotype 1 pneumonia in a United Kingdom school
Atul Gupta et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Pediatric parapneumonic empyema, Spain
Ignacio Obando et al.
EMERGING INFECTIOUS DISEASES (2008)
Vaccine escape recombinants emerge after pneumococcal vaccination in the united states
Angela B. Brueggemann et al.
PLOS PATHOGENS (2007)
Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults
Daniel A. Scott et al.
VACCINE (2007)
Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine
Stephen I. Pelton et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage
Rosalyn J. Singleton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis
Carlos G. Grijalva et al.
LANCET (2007)
The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease
William P. Hausdorff
VACCINE (2007)
Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era
William P. Hanage et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Serotype distribution of Streptococcus pneumoniae in north-western Greece and implications for a vaccination programme
Stamatina Levidiotou et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2006)
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study
Cynthia G. Whitney et al.
LANCET (2006)
Site-specific disease potential of individual Streptococcus pneumonide serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis
Dror S. Shouval et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003
Richard A. Adegbola et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2006)
Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae:: An explanation of trends in invasive pneumococcal disease
LL Hammitt et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae
MH Kyaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae:: a randomised double-blind efficacy study
R Prymula et al.
LANCET (2006)
Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema
CL Byington et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States
R Pai et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity
TW Hennessy et al.
VACCINE (2005)
An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics
J Leimkugel et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Middle ear fluid Streptococcus pneumonide serotype distribution in Costa Rican children with otitis media
A Arguedas et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Invasive pneumococcal infections among hospitalized children in Bamako, Mali
JD Campbell et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates
AB Brueggemann et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
The successful clone:: the vector of dissemination of resistance in Streptococcus pneumoniae
KP Klugman
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
S Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, part I
WP Hausdorff et al.
CLINICAL INFECTIOUS DISEASES (2000)
The contribution of specific pneumococcal serogroups to different disease manifestations: Implications for conjugate vaccine formulation and use, part II
WP Hausdorff et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
